Elie Rassy

Medical oncologist and researcher; MD, MSc, MPH

Documents

Affiliations actuelles

Institut Gustave Roussy (IGR)
Centre de recherche en épidémiologie et santé des populations (CESP)

Présentation

Hematologist, oncologist and researcher with expertise in several tumor types, my main scope of interest encloses breast cancer and cancers of unknown primary. My profound dedication and experties have led to the publication of over 200 peer-reviewed articles and several book chapters. Notably, my contributions have been featured in prestigious publications such as the Oxford Textbook of Oncology, Nature Reviews Clinical Oncology, Lancet, JAMA Oncology, and others.

I am actively engaged in promoting sustainability and advocating for the adoption of environmental, social, and governance (ESG) practices within the medical field. My commitment to driving major positive change further solidifies my reputation as a compassionate advocate for a better world.

I’m currently a medical oncologist at Gustave Roussy and mainly involved in the Breast Cancer Unit where I have co-developed several trials and translational projects aimed at improving the diagnosis and treatment of breast cancer. Concurrently, I am finishing a PhD in public health at Paris Saclay - Center for Epidemiology and Public Health.

Gustave Roussy has been named one of the world’s leading cancer-research institutes and the largest comprehensive cancer center in Europe. It ranks the third world’s best specialized hospitals in oncology 2023 according to Newsweek.

Learn more about Gustave Roussy at https://www.gustaveroussy.fr/en and CESP at https://cesp.inserm.fr/en/agent/el-rassy

Compétences

Operational & strategic experience Multinational & multicultural expertise Leadership and teambuilding abilities Excellent communication skills Extensive network & in-depth sector knowledge

Publications

	Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20–40 years Ernest Diab , Cyril Roussel-Simonin , Federica Giugliano , Julia Dixon-Douglas , Alessandra Spata et al. The Breast, 2026, 85, pp.104690. ⟨10.1016/j.breast.2025.104690⟩ Article dans une revue inserm-05610913v1
	Immune checkpoint inhibitor-associated myocarditis: a novel risk score John Power , Charles Dolladille , Benay Ozbay , Adrien Procureur , Stephane Ederhy et al. European Heart Journal, 2026, 47 (9), pp.1050-1062. ⟨10.1093/eurheartj/ehaf315⟩ Article dans une revue hal-05692720v1
	Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies Alessandra Spata , Joana Ribeiro , Paolo Vigneri , Alberto Zambelli , Jean Zeghondy et al. European Journal of Cancer, 2026, 235, pp.116230. ⟨10.1016/j.ejca.2026.116230⟩ Article dans une revue hal-05707371v1
	The rising tides of cancers among young adults F. André , E. Rassy , B. Achutti-Duso , A. Boilève , C. Smolenschi et al. ESMO Open, 2025, 10 (9), pp.105553. ⟨10.1016/j.esmoop.2025.105553⟩ Article dans une revue inserm-05302028v1
	Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians Elie Rassy , Suzette Delaloge , Yannis Slaouti , Thomas Pudlarz , Béranger Lekens et al. British Journal of Cancer, 2025, Online ahead of print. ⟨10.1038/s41416-025-03172-5⟩ Article dans une revue inserm-05233511v1
	Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort F. Giugliano , A. Bertaut , J. Blanc , A. L. Martin , M. Fournier et al. ESMO Open, 2024, 9 (12), ⟨10.1016/j.esmoop.2024.103994⟩ Article dans une revue hal-04831746v1
	Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead Thomas Grinda , Elie Rassy , Barbara Pistilli Current Treatment Options in Oncology, 2023, 24 (5), pp.466 - 467. ⟨10.1007/s11864-023-01092-1⟩ Article dans une revue inserm-04564114v1
	Exosomes in the Diagnosis and Treatment of Renal Cell Cancer Stergios Boussios , Perry Devo , Iain C A Goodall , Konstantinos Sirlantzis , Aruni Ghose et al. International Journal of Molecular Sciences, 2023, 24 (18), pp.14356. ⟨10.3390/ijms241814356⟩ Article dans une revue inserm-04563864v1
	Telehealth in breast cancer following the coronavirus disease 2019 pandemic Jean Zeghondy , Elie Rassy , Pietro Lapidari , Roland Eid , Barbara Pistilli Exploration of Targeted Anti-tumor Therapy, 2023, 4 (6), pp.1249 - 1259. ⟨10.37349/etat.2023.00195⟩ Article dans une revue inserm-04563875v1
	The paradigm shift to precision oncology between political will and cultural acceptance E. Rassy , J.-M. Heard , F. Andre ESMO Open, 2023, 8 (5), pp.101622. ⟨10.1016/j.esmoop.2023.101622⟩ Article dans une revue inserm-04521235v1
	Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials Elie Rassy , Thomas Filleron , Alessandro Viansone , Magali Lacroix-Triki , Sofia Rivera et al. Breast Cancer Research and Treatment, 2023, 199 (2), pp.371-379. ⟨10.1007/s10549-023-06912-4⟩ Article dans une revue hal-04501568v1
	Can Precision Oncology Benefit Patients With Cancers of Unknown Primary? Elie Rassy , Fabrice Andre Oncologist, 2023, 28 (10), pp.829-831. ⟨10.1093/oncolo/oyad248⟩ Article dans une revue inserm-04564091v1
	Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead Thomas Grinda , Elie Rassy , Barbara Pistilli Current Treatment Options in Oncology, 2023, 24 (5), pp.442 - 465. ⟨10.1007/s11864-023-01072-5⟩ Article dans une revue inserm-04563828v1
	Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities Christian A Linares , Anjana Varghese , Aruni Ghose , Sayali D Shinde , Sola Adeleke et al. International Journal of Molecular Sciences, 2023, 24 (17), pp.13215. ⟨10.3390/ijms241713215⟩ Article dans une revue inserm-04563908v1
	From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary Beatrice Gadiel Mathew , Fine Aliyuda , Denis Taiwo , Kehinde Adekeye , Godwin Agada et al. International Journal of Molecular Sciences, 2023, 24 (6), pp.5588. ⟨10.3390/ijms24065588⟩ Article dans une revue inserm-04563990v1
	Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study Anna Vassiliou , Temidayo Osunronbi , Synthia Enyioma , Gerardo Rago , Afroditi Karathanasi et al. Cancers, 2023, 15 (18), pp.4432. ⟨10.3390/cancers15184432⟩ Article dans une revue inserm-04564123v1
	Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study Elie Rassy , Cécile Dalban , Emeline Colomba , Lisa Derosa , Carolina Alves Costa Silva et al. Clinical Genitourinary Cancer, 2022, 20 (5), pp.488-494. ⟨10.1016/j.clgc.2022.07.003⟩ Article dans une revue hal-05744000v1
	Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies. Yuedan Zhou , Elie Rassy , Alexandre Coutte , Samir Achkar , Sophie Espenel et al. Cancers, 2022, 14 (10), ⟨10.3390/cancers14102449⟩ Article dans une revue hal-03686656v1
	Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France Rita Bentahila , Elie Rassy , Samir Achkar , Florence Sacino , Stefanos Bougas et al. Cancers, 2022, 14, ⟨10.3390/cancers14122935⟩ Article dans une revue hal-04587102v1
	A comprehensive overview of promising biomarkers in stage II colorectal cancer Pauline Parent , Romain Cohen , Elie Rassy , Magali Svrcek , Julien Taieb et al. Cancer Treatment Reviews, 2020, 88, pp.102059 -. ⟨10.1016/j.ctrv.2020.102059⟩ Article dans une revue hal-03492180v1
	The role of site-specific therapy for cancers of unknown of primary: A meta-analysis Elie Rassy , Ziad Bakouny , Toni K. Choueiri , Eliezer M. van Allen , Karim Fizazi et al. European Journal of Cancer, 2020, 127, pp.118 - 122. ⟨10.1016/j.ejca.2019.12.016⟩ Article dans une revue hal-03489893v1
	The currently declining incidence of cancer of unknown primary Elie Rassy , Nicholas Pavlidis Cancer Epidemiology, 2019, 61, pp.139 - 141. ⟨10.1016/j.canep.2019.06.006⟩ Article dans une revue hal-03485854v1

Chargement...

Elie Rassy

Présentation

Compétences

Publications

Publications

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20–40 years

Immune checkpoint inhibitor-associated myocarditis: a novel risk score

Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapies

The rising tides of cancers among young adults

Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of primary care physicians

Characteristics, treatment patterns and survival of patients with high-risk early hormone receptor-positive breast cancer in French real-world settings: an exploratory study of the CANTO cohort

Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead

Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

Telehealth in breast cancer following the coronavirus disease 2019 pandemic

The paradigm shift to precision oncology between political will and cultural acceptance

Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials

Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?

Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities

From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies.

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France

A comprehensive overview of promising biomarkers in stage II colorectal cancer

The role of site-specific therapy for cancers of unknown of primary: A meta-analysis

The currently declining incidence of cancer of unknown primary